US Intraocular Lenses Market By End User , 2018-2027

Growth Outlook

• The 2027 portion of the US Intraocular Lenses Market By End User , 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 1547 Mn in 2026 and is projected to reach USD 1643 Mn by 2027 — a gain of about 6% over the forecast period, translating to a CAGR in the mid-single digits.
• The US intraocular lenses market has been growing steadily in recent years, driven by the increasing prevalence of eye diseases and the growing demand for corrective eye surgeries. Intraocular lenses are small, artificial lenses that are implanted into the eye during cataract surgery or as a treatment for refractive vision disorders.
• What the regional split looks like (2026): Hospitals leads, holding roughly 50% of segment value — the single largest regional share. Ophthalmic Clinics is the second-largest contributor. Others make up the remainder, in descending order.
• By 2027, Hospitals alone is expected to reach USD 825 Mn, with Ophthalmic Clinics at USD 529 Mn.

Market Dynamics

The US intraocular lenses market has been growing steadily in recent years, driven by the increasing prevalence of eye diseases and the growing demand for corrective eye surgeries. Intraocular lenses are small, artificial lenses that are implanted into the eye during cataract surgery or as a treatment for refractive vision disorders. They replace the eye's natural lens, which has become cloudy or damaged, and help to restore visual acuity. One of the key end-users of intraocular lenses is the ophthalmology clinics and hospitals. These facilities play a crucial role in the diagnosis, treatment, and management of eye diseases and disorders. With the rise in the aging population and the consequent increase in age-related eye diseases such as cataracts, there has been a surge in demand for ophthalmological services, including cataract surgery. According to the American Academy of Ophthalmology, around 24.4 million Americans aged 40 and above have cataracts, and this number is expected to increase to 38.7 million by 2032. With the majority of cataract surgeries being performed in outpatient settings, the demand for intraocular lenses from ophthalmology clinics and hospitals is expected to continue to grow. Another key end-user of intraocular lenses is the ambulatory surgical centers (ASCs).

These facilities are dedicated to performing same-day surgeries, including cataract surgeries. As cataracts are the leading cause of blindness worldwide, ASCs have a pivotal role in providing accessible and cost-effective cataract surgeries. The rising trend towards same-day surgeries and the increasing adoption of minimally invasive procedures have led to the growth of ASCs, which in turn has fueled the demand for intraocular lenses. The rise in popularity of premium intraocular lenses has also been a driving force behind the market growth. Unlike traditional monofocal lenses, premium intraocular lenses can correct multiple vision disorders, including nearsightedness, farsightedness, and astigmatism. This has led to an increase in demand for premium intraocular lenses from private ophthalmology clinics and hospitals, where patients seek more advanced and personalized treatments. In addition to these end-users, the aging population, the prevalence of eye diseases, and the advancements in technology are also significant factors contributing to the growth of the US intraocular lenses market. As the healthcare sector continues to evolve, the demand for intraocular lenses is expected to continue to grow, driven by the need for advanced treatments and improved visual outcomes for patients.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.